tiprankstipranks
Advertisement
Advertisement

HK:2126 Stock Latest News

JW Therapeutics Grants CEO 2 Million Performance-Linked Share Options
Company AnnouncementsJW Therapeutics Grants CEO 2 Million Performance-Linked Share Options
6d ago
JW Therapeutics Grants New Equity Awards to Employees Under Post-IPO Schemes
PremiumCompany Announcements
JW Therapeutics Grants New Equity Awards to Employees Under Post-IPO Schemes
1M ago
JW Therapeutics Boosts 2025 Revenue on CAR-T Sales and Licensing but Books Major Pipeline Impairments
PremiumCompany Announcements
JW Therapeutics Boosts 2025 Revenue on CAR-T Sales and Licensing but Books Major Pipeline Impairments
2M ago
JW Therapeutics Schedules Board Meeting to Approve 2025 Results and Consider Dividend
PremiumCompany Announcements
JW Therapeutics Schedules Board Meeting to Approve 2025 Results and Consider Dividend
3M ago
JW Therapeutics Grants New Share Options and RSUs to CEO and Key Staff
PremiumCompany Announcements
JW Therapeutics Grants New Share Options and RSUs to CEO and Key Staff
4M ago
JW Therapeutics Outlines Board and Committee Structure
PremiumCompany AnnouncementsJW Therapeutics Outlines Board and Committee Structure
5M ago
JW Therapeutics Extends Vector Supply Agreement With Juno to 2028
Premium
Company Announcements
JW Therapeutics Extends Vector Supply Agreement With Juno to 2028
5M ago
JW Therapeutics Announces Key Leadership Changes
Premium
Company Announcements
JW Therapeutics Announces Key Leadership Changes
5M ago
JW Therapeutics Announces Board Composition and Roles
PremiumCompany Announcements
JW Therapeutics Announces Board Composition and Roles
5M ago
JW Therapeutics Reports Promising Results for JWCAR201 in Hematology Study
PremiumCompany Announcements
JW Therapeutics Reports Promising Results for JWCAR201 in Hematology Study
6M ago
JW Cayman and Regeneron Amend Collaboration for Oncology Product Development
PremiumCompany Announcements
JW Cayman and Regeneron Amend Collaboration for Oncology Product Development
7M ago
JW Therapeutics Advances SLE Treatment with Promising Phase I Results
PremiumCompany Announcements
JW Therapeutics Advances SLE Treatment with Promising Phase I Results
7M ago
JW Therapeutics Advances with In-House Lentiviral Vector for Carteyva®
PremiumCompany AnnouncementsJW Therapeutics Advances with In-House Lentiviral Vector for Carteyva®
8M ago
JW Therapeutics Delays Circular Dispatch for Incentivization Scheme
Premium
Company Announcements
JW Therapeutics Delays Circular Dispatch for Incentivization Scheme
8M ago
JW Therapeutics Announces Share Options Grant to CEO
Premium
Company Announcements
JW Therapeutics Announces Share Options Grant to CEO
8M ago
JW Therapeutics Reports Revenue Growth Amid Operational Improvements
PremiumCompany Announcements
JW Therapeutics Reports Revenue Growth Amid Operational Improvements
9M ago
JW Therapeutics to Review Interim Results in Upcoming Board Meeting
PremiumCompany Announcements
JW Therapeutics to Review Interim Results in Upcoming Board Meeting
9M ago
JW Therapeutics Announces Unanimous Approval of AGM Resolutions
PremiumCompany Announcements
JW Therapeutics Announces Unanimous Approval of AGM Resolutions
11M ago
JW Therapeutics Approves License Agreement at EGM
PremiumCompany Announcements
JW Therapeutics Approves License Agreement at EGM
12M ago
JW Therapeutics Advances Cancer Treatment with NMPA Acceptance
PremiumCompany AnnouncementsJW Therapeutics Advances Cancer Treatment with NMPA Acceptance
12M ago
JW Therapeutics Announces Extraordinary General Meeting for License Agreement Approval
Premium
Company Announcements
JW Therapeutics Announces Extraordinary General Meeting for License Agreement Approval
1y ago
JW Therapeutics Announces Closure of Register for Upcoming EGM
Premium
Company Announcements
JW Therapeutics Announces Closure of Register for Upcoming EGM
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >